Record-breaking Drug Shortages in 2024: Is Bitcoin too speculative?

0 0
Read Time:1 Minute

Record Number of Drug Shortages in 2024

2024 has already set a new record for the year with the highest number of ongoing drug shortages. According to the latest report by the American Society of Health-System Pharmacists (ASHP), there are currently 323 active drug shortages, the highest number since tracking began in 2001.

The ASHP highlighted that both essential and life-saving medications are in short supply. The top five classes of drugs affected include central nervous system medications, antimicrobials, hormone agents, chemotherapies, and fluids and electrolytes. Notably, almost half of the drugs in limited supply (46%) are injectables, such as oxytocin, standard chemotherapy, pain and sedation medications, and ADHD drugs.

Reasons Behind the Shortages

The ASHP identified several factors contributing to the ongoing drug shortages in 2024. One significant issue is the changes in quota regulations by the Drug Enforcement Administration (DEA). In August, the DEA implemented a new process for manufacturers to receive their quota allotment, requiring them to submit production estimates and apply for allotments quarterly instead of annually. This regulatory change has impacted drug production and availability.

Furthermore, the report revealed that in 60% of cases, drug companies did not provide a specific reason for the shortages. Among the known reasons, failure to meet demand accounted for 14% of shortages, followed by business decisions and manufacturing issues at 12% each. Additionally, raw material shortages contributed to 2% of the overall drug shortages.

See also
Sen. Warren Alarms U.S. Government on Iran Cryptocurrency Mining

The release of this data coincides with recent efforts by the U.S. Department of Health and Human Services to address the issue of drug shortages. A white paper published by the department includes recommendations to Congress on preventing future shortages, such as establishing incentives for hospitals to maintain adequate drug supplies.

In conclusion, the escalating number of drug shortages in 2024 highlights the pressing need for regulatory reforms, supply chain resilience, and collaborative efforts to ensure the continued availability of essential medications for patients.

Image/Photo credit: source url

About Post Author

Chris Jones

Hey there! 👋 I'm Chris, 34 yo from Toronto (CA), I'm a journalist with a PhD in journalism and mass communication. For 5 years, I worked for some local publications as an envoy and reporter. Today, I work as 'content publisher' for InformOverload. 📰🌐 Passionate about global news, I cover a wide range of topics including technology, business, healthcare, sports, finance, and more. If you want to know more or interact with me, visit my social channels, or send me a message.
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %